596. DeLong MR, Huang KT, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP. Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease. JAMA Neurol. 2014 Oct;71(10):1290-5. doi: 10.1001/jamaneurol.2014.1272. PMID: 25155481.
597. Mansouri A, Taslimi S, Badhiwala JH, Witiw CD, Nassiri F, Odekerken VJJ, De Bie RMA, Kalia SK, Hodaie M, Munhoz RP, Fasano A, Lozano AM. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018 Apr;128(4):1199-1213. doi: 10.3171/2016.11.JNS16715. Epub 2017 Jun 30. PMID: 28665252.
598. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D; CSP-468 Study Group. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):622-9. doi: 10.1136/jnnp-2014-308119. Epub 2014 Sep 2. PMID: 25185211.
599. Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE, Rodriguez-Oroz MC, Tamma F, Tröster AI, Vitek JL, Volkmann J, Voon V. Deep brain stimulation: postoperative issues. Mov Disord. 2006 Jun;21 Suppl 14:S219-37. doi: 10.1002/mds.20957. PMID: 16810719.
600. Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson’s disease. Mov Disord 2006;21: S284–9
601. Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord. 2002;17 Suppl 3:S181-7. doi: 10.1002/mds.10162. PMID: 11948775.
602. Deaths from Neurodegenerative Diseases in England, 2002 to 2008. National end of life care intelligence network. №1, 2010
603. Gomes B, Calanzani N, Gysels M, Hall S, Higginson I. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliative Care. 2013;12(7):1–13. doi: 10.1186/1472-684X-12-7
604. Annette Hand, William K. Gray, Lloyd L. Oates, Megan Woolford, Anna Todd, Elizabeth Bale, Catherine Jones, Brian H. Wood, Richard W. Walker. Medication use in people with late stage Parkinson's disease and parkinsonism living at home and in institutional care in north-east England: A balance of symptoms and side-effects? Parkinsonism and Related Disorders 32 (2016) 120-123.doi: 10.1016/j.parkreldis.2016.09.001
605. Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial. JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992
606. Holford N, Nutt JG. Disease progression, drug action and Parkinson's disease: why time cannot be ignored. Eur J Clin Pharmacol. 2008 Feb; 64(2):20716. DOI: 10.1007/s00228-007-0427-9
607. Logemann J.A., Gensler G., Robbins J., et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res. 2008; 51(1):173-183.
608. Flynn E., Smith C.H., Walsh C.D., et al. Modifying the consistency of food and fluids for swallowing difficulties in dementia. Cochrane Database Syst Rev. 2018;9(9):CD011077.
609. Newman R., Vilardell N., Clavé P., et al. Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing Disorders (ESSD). Dysphagia. 2016;31(2):232-249.
610. El Sharkawi A., Ramig L., Logemann J.A., et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry. 2002;72(1):31-36.
611. Miles A., Jardine M., Johnston F., et al. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study. J Neurol Sci. 2017; 383:180-187.
612. Pitts D., Bolser J., Rosenbek M. et al. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest. 2009; 135: 1301- 1308.
613. van Hooren M.R., Baijens L.W., Voskuilen S., et al. Treatment effects for dysphagia in Parkinson's disease: a systematic review.Parkinsonism & related disorders. 2014; 20(8):800–807.
614. Warnecke I., Suttrup J.B., Schroder N., et al. Dziewas Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test Parkinsonism Relat. Disord. 2016; 28: 100-106
615. Lim A., Leow L., Huckabee M.L., et al. A pilot study of respiration and swallowing integration in Parkinson's disease: “on” and “off” levodopa. Dysphagia. 2008; 23:76– 81.
616. Hunter P.C., Crameri J., Austin S., et al. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry. 1997; 63: 579–583.
617. Hirano M., Isono C., Sakamoto H., et al. Rotigotine transdermal patch improves swallowing in dysphagic patients with Parkinson's disease. Dysphagia. 2015; 30: 452-456.
618. Yu H., Takahashi K., Bloom L., et al. Effect of Deep Brain Stimulation on Swallowing Function: A Systematic Review. Front Neurol. 2020; 11:547.
619. Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ, Richfield EW, Bekelman D, Kutner JS, Miyasaki J. Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017 Apr;37:19-26. doi: 10.1016/j.parkreldis.2017.01.008. Epub 2017 Jan 11. PMID: 28108265.
620. Oliver D, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R.A. Consensus review on the development of palliative care for patients with chronic and progressive neurological disease Eur J Neurol. 2016 Jan;23(1):30-8 doi: 10.1111/ene.12889. Epub 2015 Oct 1